Novel high-resolution contrast agent ultrasound techniques HiFR CEUS and SR CEUS in combination with shear wave elastography, fat assessment and viscosity of liver parenchymal changes and tumors

Ernst Michael Jung(University Hospital Regensburg), F. Jung(Brandenburg University of Technology Cottbus-Senftenberg), Christian Stroszczynski(University Hospital Carl Gustav Carus), Ulrich Kaiser(University of Applied Sciences Landshut), Wolfgang Herr(University Hospital Regensburg)
Clinical Hemorheology and Microcirculation
March 12, 2024
10.3233/ch-249103
Cited by 21

Related Papers

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
|The Lancet|2013|1.5k
Vascular Endothelial Cell Biology: An Update
|International Journal of Molecular Sciences|2019|1.1k
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
|The Lancet Oncology|2009|960
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
|Cell Reports|2019|297